The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Association of Personalized and Tumor-Informed Ctdna with Patient Survival Outcomes in Pancreatic Adenocarcinoma.
 
Gregory P. Botta
Honoraria - Natera
Consulting or Advisory Role - Natera
Speakers' Bureau - Natera
 
Maen Abdelrahim
No Relationships to Disclose
 
Vasily N. Aushev
Employment - Natera
Stock and Other Ownership Interests - Natera
Travel, Accommodations, Expenses - Natera
 
Abdullah Esmail
Employment - Houston Methodist Cancer Center
 
Bridgette Drummond
Employment - Natera
Stock and Other Ownership Interests - Natera
Research Funding - Natera
Travel, Accommodations, Expenses - Natera
 
Shruti Sharma
Employment - Natera
Stock and Other Ownership Interests - Natera
 
Ekaterina Kalashnikova
Employment - Natera
Stock and Other Ownership Interests - Natera
Research Funding - Natera
 
Nicole Hook
Employment - Natera
Stock and Other Ownership Interests - Natera
Research Funding - Natera
Travel, Accommodations, Expenses - Natera
 
Sreenivasa R Chandana
Consulting or Advisory Role - Amgen; AstraZeneca; Dicephera Pharmaceuticals, Inc.; E.R. Squibb Sons, LLC; Johnson & Johnson/Janssen; Lilly
Speakers' Bureau - Amgen; Eisai; IPSEN; JNJ; Novartis
Research Funding - Abbvie (Inst); Alexion Pharmaceuticals (Inst); Alexion Pharmaceuticals (Inst); Alexo Therapeutics (Inst); ArQule (Inst); Asana Biosciences (Inst); Ascentage Pharma (Inst); BeiGene (Inst); BMS (Inst); Cerulean Pharma (Inst); Constellation Pharmaceuticals (Inst); Daiichi Sankyo (Inst); Dicerna (Inst); Formation Biologics (Inst); Forty Seven (Inst); Livzon (Inst); Loxo (Inst); Macrogenics (Inst); Merck (Inst); Pfizer (Inst); Regeneron (Inst); Symphony Evolution (Inst); TaiRx, Inc. (Inst)
 
Mohamedtaki Abdulaziz Tejani
Consulting or Advisory Role - Exelixis
Speakers' Bureau - Natera
Research Funding - Bayer (Inst)
 
Midhun Malla
Honoraria - Omni health
Consulting or Advisory Role - AstraZeneca; QED therapeutics
 
Liudmila N. Schafer
No Relationships to Disclose
 
Pashtoon Murtaza Kasi
Consulting or Advisory Role - AstraZeneca; Axiom Healthcare Strategies; Bayer; Boston Healthcare Associates; Delcath Systems; Foundation Medicine; Inflecton Point Biomedical Advisors; Ipsen (Inst); Lilly; MSD Oncology; Natera; QED Therapeutics; Taiho Pharmaceutical (Inst); Tempus
Research Funding - Advanced Accelerator Applications (Inst); Array BioPharma (Inst); Boston Scientific (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Tersera (Inst)
Travel, Accommodations, Expenses - AstraZeneca
 
Giby V. George
Employment - Natera
Stock and Other Ownership Interests - Natera
Research Funding - Natera
 
Alexey Aleshin
Employment - Natera; Natera
Leadership - Natera
Stock and Other Ownership Interests - Natera
Consulting or Advisory Role - Mission Bio; Mission Bio
Travel, Accommodations, Expenses - Natera
 
Farshid Dayyani
Employment - Roche (I)
Consulting or Advisory Role - Array BioPharma; Eisai; Exelixis; Genentech/Roche; QED Therapeutics; Signatera
Speakers' Bureau - Amgen; Deciphera; Eisai; Exelixis; Genentech/Roche; ipsen; Natera; SERVIER; Sirtex Medical
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Exelixis (Inst); Genentech (Inst); Ipsen (Inst); Merck (Inst); Taiho Pharmaceutical (Inst)
 
Diana L. Hanna
Consulting or Advisory Role - Boehringer Ingelheim